Nitrosamine Impurities

Addressing the Evolving Nitrosamine Contamination Issue

Olon

Process Validation

Streamlining Process Validation for Drug Substance Manufacturing

Gerhard Noessner, Ph.D.; Juergen Utz, Ph.D.; Juergen Bank, Ph.D.

Fareva

Biologics

New Method Developed for Stereoselective Synthesis of Biologic Drug Substances

Emilie Branch

Pharma's Almanac

CFDA

China FDA Publishes Guidance for Priority Review

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Biosimilars

Pfizer Receives FDA Approval for Remicade® Biosimilar

Nice Insight

Drug Delivery

Needle-Free Injection Technology Advances to Phase II Trial

Nice Insight

Investment

Transporters Targeting Cell’s Metabolic Gates Win Financing

Nice Insight

Drug Delivery

Needle-Free Injection Technology Advances to Phase II Trial

Nice Insight

FDA

NDA Submitted for Antimalarial Drug

Nice Insight

Research

Tumor Killing Combo Wins Third U.S. Patent

Nice Insight

Drug Development

Chinese Biopharma Receives Series A Financing

Nice Insight

Strategic Partnership

BioVectra and Keryx Expand Strategic API Supply Relationship

Nice Insight

Diabetes

First “Follow-On” Insulin Product Approved

Nice Insight

3D Printing

Aprecia and Cycle Team to Develop 3D-Printed Orphan Drugs

Nice Insight